Neuroscience News

This week, we talk with our founding director, Bill Newsome, about the 10-year legacy of the NIH BRAIN Initiative and the uncertainty for the future brought on by this year's dramatic funding cuts.

This week we are talking with Stanford neuroscientist Ivan Soltesz about endocannabinoids, illuminating the "day job" of these unusual neurotransmitters and how they may be hijacked by cannabinoid drugs such as THC and CBD.

Laura Gwilliams, a Wu Tsai Neuro faculty scholar, and Brian Hie are the inaugural faculty of Stanford Data Science.

This week we are talking with Stanford neurobiologist Lisa Giocomo, exploring the intersection of memory, navigation, and the boundaries we create between ourselves and the world around us.

Stanford undergraduates and local community college students showcased their summer research projects at the Wu Tsai Neurosciences Institute, highlighting efforts to introduce students to neuroscience research for the first time.

The 2024 NeuroTech trainees at Wu Tsai Neuro are advancing neurotechnology through interdisciplinary research and collaboration, combining expertise from fields like bioengineering, computer science, and electrical engineering.

Introducing the 2024 MBCT student members, PhD students advancing neuroscience through interdisciplinary research that spans psychology, biology, engineering, and more.

Meet the 2024 Stanford Interdisciplinary Graduate Fellows supported by the Wu Tsai Neurosciences Institute who are driving cutting-edge, interdisciplinary neuroscience research.

The Knight Initiative for Brain Resilience supports 14 high-risk, high-reward projects to advance brain health and resilience research, fostering bold research across various scientific disciplines.

A collaboration between Institute Faculty Scholars Julia Kaltschmidt and Todd Coleman has identified a key step in nervous system control over gut motility, opening new opportunities for understanding GI disorders in premature infants

Study in mice, supported by the Knight Initiative, suggests that an experimental cancer drug boosted brain metabolism, restored memory, and improved Alzheimer's symptoms. This novel approach may offer a new way to treat Alzheimer's beyond targeting amyloid plaques.

The APOE4 genetic variant, carried by about 20% of people, significantly raises Alzheimer’s risk. But should we boost the gene’s potency or suppress it? A recent discovery by Knight Initiative affiliate, Mike Greicius, may provide the answers we need.

Institute affiliates Brad Zuchero, Justin Du Bois and colleagues discovered that neurons require signaling from glia to become fully excitable, rather than by becoming excitable by default.

Groundbreaking research supported by the Knight Initiative for Brain Resilience at Stanford’s Wu Tsai Neurosciences Institute deepens our understanding of how the amino acid taurine may help reduce appetite and prevent obesity.

Wu Tsai Neuro affiliate Lisa Giocomo has been named a Howard Hughes Medical Institute (HHMI) Investigator in the neurosciences, along with 10 other Stanford HHMI Investigators. This award highlights her exceptional research and dedication to mentoring the next generation of scientists.

The Knight Initiative's Year-End Symposium and Research Showcase featured a wide range of promising new approaches to understanding brain aging, resilience, and neurodegeneration.